Asia Pacific Pharma 4.0 Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Technology, By Country and Growth Forecast, 2024

List of Tables

The Asia Pacific Pharma 4.0 Market would witness market growth of 19.2% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Pharma 4.0 Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,482.8 million by 2031. The Japan market is registering a CAGR of 18.6% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 20% during (2024 - 2031).

AI is transforming this paradigm by analyzing vast datasets of molecular structures, genetic information, clinical trial data, and patient outcomes to uncover hidden relationships between drugs and diseases. One of the most well-known examples of AI in drug repurposing comes from BenevolentAI, a UK-based company that leverages AI for drug discovery. BenevolentAI's platform was used to analyze scientific literature and databases to identify existing drugs that could potentially treat COVID-19.

The use of AI in drug repurposing is also extending into neurological diseases. Neurological conditions, such as Alzheimer's and Parkinson's, are notoriously difficult to treat, with very few effective treatments available. AI is being used to search for existing drugs that could be repurposed to slow the progression of these diseases. For instance, Insilico Medicine, a biotech company specializing in AI-driven drug discovery, has applied AI to find potential candidates for Alzheimer's treatment by repurposing drugs already approved for other conditions.

In Japan, the increasing demand for this 4.0 is primarily driven by the rising healthcare needs associated with the country's aging population. As of October 2022, the population aged 65 and above in Japan amounted to 36,236 thousand, constituting 29.0 percent of the overall population, as the Statistics Bureau of Japan reported. This demographic shift has created a need for more advanced, efficient healthcare solutions, including personalized medicine and precision healthcare. The government's "Society 5.0" initiative aims to integrate digital technologies like IoT and AI into various industries, including healthcare and pharmaceuticals. By leveraging this 4.0 technologies, Japan is enhancing drug development and manufacturing to meet the healthcare demands of its aging population while reducing the strain on healthcare resources. Therefore, the region's diverse economic landscapes, combined with government-backed programs and initiatives, are accelerating the integration of Pharma 4.0, making Asia-Pacific a key player in the global pharmaceutical transformation.

Based on Type, the market is segmented into Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Manufacturing, Supply Chain Management, and Other Application. Based on End Use, the market is segmented into Pharma & Biotech companies, CRO & CDMO, and Healthcare Providers. Based on Technology, the market is segmented into AI & ML, Big Data Analytics, IoT, Blockchain Technology, and Other Technology. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Amazon Web Services, Inc.
SAP SE
Oracle Corporation
Microsoft Corporation
IBM Corporation
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cisco Systems, Inc.
Dassault Systemes SE
UnitedHealth Group, Inc. (Optum, Inc.)

Asia Pacific Pharma 4.0 Market Report Segmentation

By Type

Software
Services

By Application

Drug Discovery & Development
Manufacturing
Supply Chain Management
Other Application

By End Use

Pharma & Biotech companies
CRO & CDMO
Healthcare Providers

By Technology

AI & ML
Big Data Analytics
IoT
Blockchain Technology
Other Technology

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Pharma 4.0 Market, by Type
- 1.4.2 Asia Pacific Pharma 4.0 Market, by Application
- 1.4.3 Asia Pacific Pharma 4.0 Market, by End Use
- 1.4.4 Asia Pacific Pharma 4.0 Market, by Technology
- 1.4.5 Asia Pacific Pharma 4.0 Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, May - 2024, Sep) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. Asia Pacific Pharma 4.0 Market by Type

5.1 Asia Pacific Software Market by Country
5.2 Asia Pacific Services Market by Country

Chapter 6. Asia Pacific Pharma 4.0 Market by Application

6.1 Asia Pacific Drug Discovery & Development Market by Country
6.2 Asia Pacific Manufacturing Market by Country
6.3 Asia Pacific Supply Chain Management Market by Country
6.4 Asia Pacific Other Application Market by Country

Chapter 7. Asia Pacific Pharma 4.0 Market by End Use

7.1 Asia Pacific Pharma & Biotech companies Market by Country
7.2 Asia Pacific CRO & CDMO Market by Country
7.3 Asia Pacific Healthcare Providers Market by Country

Chapter 8. Asia Pacific Pharma 4.0 Market by Technology

8.1 Asia Pacific AI & ML Market by Country
8.2 Asia Pacific Big Data Analytics Market by Country
8.3 Asia Pacific IoT Market by Country
8.4 Asia Pacific Blockchain Technology Market by Country
8.5 Asia Pacific Other Technology Market by Country

Chapter 9. Asia Pacific Pharma 4.0 Market by Country

9.1 China Pharma 4.0 Market
- 9.1.1 China Pharma 4.0 Market by Type
- 9.1.2 China Pharma 4.0 Market by Application
- 9.1.3 China Pharma 4.0 Market by End Use
- 9.1.4 China Pharma 4.0 Market by Technology
9.2 Japan Pharma 4.0 Market
- 9.2.1 Japan Pharma 4.0 Market by Type
- 9.2.2 Japan Pharma 4.0 Market by Application
- 9.2.3 Japan Pharma 4.0 Market by End Use
- 9.2.4 Japan Pharma 4.0 Market by Technology
9.3 India Pharma 4.0 Market
- 9.3.1 India Pharma 4.0 Market by Type
- 9.3.2 India Pharma 4.0 Market by Application
- 9.3.3 India Pharma 4.0 Market by End Use
- 9.3.4 India Pharma 4.0 Market by Technology
9.4 South Korea Pharma 4.0 Market
- 9.4.1 South Korea Pharma 4.0 Market by Type
- 9.4.2 South Korea Pharma 4.0 Market by Application
- 9.4.3 South Korea Pharma 4.0 Market by End Use
- 9.4.4 South Korea Pharma 4.0 Market by Technology
9.5 Singapore Pharma 4.0 Market
- 9.5.1 Singapore Pharma 4.0 Market by Type
- 9.5.2 Singapore Pharma 4.0 Market by Application
- 9.5.3 Singapore Pharma 4.0 Market by End Use
- 9.5.4 Singapore Pharma 4.0 Market by Technology
9.6 Malaysia Pharma 4.0 Market
- 9.6.1 Malaysia Pharma 4.0 Market by Type
- 9.6.2 Malaysia Pharma 4.0 Market by Application
- 9.6.3 Malaysia Pharma 4.0 Market by End Use
- 9.6.4 Malaysia Pharma 4.0 Market by Technology
9.7 Rest of Asia Pacific Pharma 4.0 Market
- 9.7.1 Rest of Asia Pacific Pharma 4.0 Market by Type
- 9.7.2 Rest of Asia Pacific Pharma 4.0 Market by Application
- 9.7.3 Rest of Asia Pacific Pharma 4.0 Market by End Use
- 9.7.4 Rest of Asia Pacific Pharma 4.0 Market by Technology

Chapter 10. Company Profiles

10.1 Amazon Web Services, Inc. (Amazon.com, Inc.)
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental Analysis
- 10.1.4 Recent strategies and developments:
  - 10.1.4.1 Partnerships, Collaborations, and Agreements:
- 10.1.5 SWOT Analysis
10.2 Oracle Corporation
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Partnerships, Collaborations, and Agreements:
  - 10.2.5.2 Acquisition and Mergers:
- 10.2.6 SWOT Analysis
10.3 Microsoft Corporation
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expenses
- 10.3.5 Recent strategies and developments:
  - 10.3.5.1 Product Launches and Product Expansions:
- 10.3.6 SWOT Analysis
10.4 IBM Corporation
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional & Segmental Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 Recent strategies and developments:
  - 10.4.5.1 Partnerships, Collaborations, and Agreements:
  - 10.4.5.2 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
10.5 SAP SE
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
  - 10.5.5.1 Partnerships, Collaborations, and Agreements:
  - 10.5.5.2 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
10.6 GE HealthCare Technologies, Inc.
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental and Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 Recent strategies and developments:
  - 10.6.5.1 Product Launches and Product Expansions:
- 10.6.6 SWOT Analysis
10.7 Siemens Healthineers AG (Siemens AG)
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental and Regional Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 Recent strategies and developments:
  - 10.7.5.1 Partnerships, Collaborations, and Agreements:
- 10.7.6 SWOT Analysis
10.8 Cisco Systems, Inc.
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expense
- 10.8.5 Recent strategies and developments:
  - 10.8.5.1 Partnerships, Collaborations, and Agreements:
- 10.8.6 SWOT Analysis
10.9 Dassault Systemes SE
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expense
- 10.9.5 Recent strategies and developments:
  - 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
10.10. UnitedHealth Group, Inc. (Optum, Inc.)
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Segmental Analysis

LIST OF TABLES

TABLE 1 Asia Pacific Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 2 Asia Pacific Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Pharma 4.0 Market
TABLE 4 Product Launches And Product Expansions- Pharma 4.0 Market
TABLE 5 Acquisition and Mergers- Pharma 4.0 Market
TABLE 6 Asia Pacific Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 7 Asia Pacific Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 8 Asia Pacific Software Market by Country, 2020 - 2023, USD Million
TABLE 9 Asia Pacific Software Market by Country, 2024 - 2031, USD Million
TABLE 10 Asia Pacific Services Market by Country, 2020 - 2023, USD Million
TABLE 11 Asia Pacific Services Market by Country, 2024 - 2031, USD Million
TABLE 12 Asia Pacific Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 13 Asia Pacific Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 14 Asia Pacific Drug Discovery & Development Market by Country, 2020 - 2023, USD Million
TABLE 15 Asia Pacific Drug Discovery & Development Market by Country, 2024 - 2031, USD Million
TABLE 16 Asia Pacific Manufacturing Market by Country, 2020 - 2023, USD Million
TABLE 17 Asia Pacific Manufacturing Market by Country, 2024 - 2031, USD Million
TABLE 18 Asia Pacific Supply Chain Management Market by Country, 2020 - 2023, USD Million
TABLE 19 Asia Pacific Supply Chain Management Market by Country, 2024 - 2031, USD Million
TABLE 20 Asia Pacific Other Application Market by Country, 2020 - 2023, USD Million
TABLE 21 Asia Pacific Other Application Market by Country, 2024 - 2031, USD Million
TABLE 22 Asia Pacific Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 23 Asia Pacific Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 24 Asia Pacific Pharma & Biotech companies Market by Country, 2020 - 2023, USD Million
TABLE 25 Asia Pacific Pharma & Biotech companies Market by Country, 2024 - 2031, USD Million
TABLE 26 Asia Pacific CRO & CDMO Market by Country, 2020 - 2023, USD Million
TABLE 27 Asia Pacific CRO & CDMO Market by Country, 2024 - 2031, USD Million
TABLE 28 Asia Pacific Healthcare Providers Market by Country, 2020 - 2023, USD Million
TABLE 29 Asia Pacific Healthcare Providers Market by Country, 2024 - 2031, USD Million
TABLE 30 Asia Pacific Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 31 Asia Pacific Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 32 Asia Pacific AI & ML Market by Country, 2020 - 2023, USD Million
TABLE 33 Asia Pacific AI & ML Market by Country, 2024 - 2031, USD Million
TABLE 34 Asia Pacific Big Data Analytics Market by Country, 2020 - 2023, USD Million
TABLE 35 Asia Pacific Big Data Analytics Market by Country, 2024 - 2031, USD Million
TABLE 36 Asia Pacific IoT Market by Country, 2020 - 2023, USD Million
TABLE 37 Asia Pacific IoT Market by Country, 2024 - 2031, USD Million
TABLE 38 Asia Pacific Blockchain Technology Market by Country, 2020 - 2023, USD Million
TABLE 39 Asia Pacific Blockchain Technology Market by Country, 2024 - 2031, USD Million
TABLE 40 Asia Pacific Other Technology Market by Country, 2020 - 2023, USD Million
TABLE 41 Asia Pacific Other Technology Market by Country, 2024 - 2031, USD Million
TABLE 42 Asia Pacific Pharma 4.0 Market by Country, 2020 - 2023, USD Million
TABLE 43 Asia Pacific Pharma 4.0 Market by Country, 2024 - 2031, USD Million
TABLE 44 China Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 45 China Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 46 China Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 47 China Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 48 China Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 49 China Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 50 China Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 51 China Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 52 China Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 53 China Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 54 Japan Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 55 Japan Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 56 Japan Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 57 Japan Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 58 Japan Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 59 Japan Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 60 Japan Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 61 Japan Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 62 Japan Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 63 Japan Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 64 India Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 65 India Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 66 India Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 67 India Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 68 India Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 69 India Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 70 India Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 71 India Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 72 India Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 73 India Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 74 South Korea Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 75 South Korea Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 76 South Korea Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 77 South Korea Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 78 South Korea Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 79 South Korea Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 80 South Korea Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 81 South Korea Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 82 South Korea Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 83 South Korea Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 84 Singapore Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 85 Singapore Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 86 Singapore Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 87 Singapore Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 88 Singapore Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 89 Singapore Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 90 Singapore Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 91 Singapore Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 92 Singapore Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 93 Singapore Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 94 Malaysia Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 95 Malaysia Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 96 Malaysia Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 97 Malaysia Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 98 Malaysia Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 99 Malaysia Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 100 Malaysia Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 101 Malaysia Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 102 Malaysia Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 103 Malaysia Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 104 Rest of Asia Pacific Pharma 4.0 Market, 2020 - 2023, USD Million
TABLE 105 Rest of Asia Pacific Pharma 4.0 Market, 2024 - 2031, USD Million
TABLE 106 Rest of Asia Pacific Pharma 4.0 Market by Type, 2020 - 2023, USD Million
TABLE 107 Rest of Asia Pacific Pharma 4.0 Market by Type, 2024 - 2031, USD Million
TABLE 108 Rest of Asia Pacific Pharma 4.0 Market by Application, 2020 - 2023, USD Million
TABLE 109 Rest of Asia Pacific Pharma 4.0 Market by Application, 2024 - 2031, USD Million
TABLE 110 Rest of Asia Pacific Pharma 4.0 Market by End Use, 2020 - 2023, USD Million
TABLE 111 Rest of Asia Pacific Pharma 4.0 Market by End Use, 2024 - 2031, USD Million
TABLE 112 Rest of Asia Pacific Pharma 4.0 Market by Technology, 2020 - 2023, USD Million
TABLE 113 Rest of Asia Pacific Pharma 4.0 Market by Technology, 2024 - 2031, USD Million
TABLE 114 Key Information - Amazon Web Services, Inc.
TABLE 115 Key Information - Oracle Corporation
TABLE 116 Key Information - Microsoft Corporation
TABLE 117 Key Information - IBM Corporation
TABLE 118 Key Information - SAP SE
TABLE 119 Key Information - GE HealthCare Technologies, Inc.
TABLE 120 Key Information - Siemens Healthineers AG
TABLE 121 Key Information - Cisco Systems, Inc.
TABLE 122 Key Information - Dassault Systemes SE
TABLE 123 Key Information - UnitedHealth Group, Inc.

Asia Pacific Pharma 4.0 Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Technology, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents